Home/Pipeline/OnyMed

OnyMed

Nail Diseases (e.g., Onychomycosis)

Not SpecifiedDevelopment

Key Facts

Indication
Nail Diseases (e.g., Onychomycosis)
Phase
Not Specified
Status
Development
Company

About Ascil Biopharm

Ascil Biopharm is a Barcelona-based biotech company with a dual business model: developing its own innovative drug delivery systems and providing contract development and manufacturing (CDMO) services. The company specializes in complex formulations for systemic and locoregional delivery, with a clinical-stage pipeline and a portfolio of proprietary medical devices. Its strategy leverages European grant funding and aims to address unmet medical needs through enhanced drug efficacy, safety, and patient convenience.

View full company profile